HC
Highmount Capital Portfolio holdings
AUM
$391M
Turnover
10.22%
1-Year Est. Return
2.65%
This Fund
S&P 500
This Quarter
Est. Return
+7.41%
1 Year Est. Return
+2.65%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$435M
AUM Growth
+$29.9M
(+7.4%)
Cap. Flow
+$4.18M
Cap. Flow
% of AUM
0.96%
Top 10 Holdings %
Top 10 Hldgs %
46.97%
Holding
148
New
18
Increased
60
Reduced
30
Closed
4
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$3.16M |
| 2 |
Agilent Technologies
A
|
+$3.06M |
| 3 |
Citigroup
C
|
+$3.02M |
| 4 |
Travel + Leisure Co
TNL
|
+$2.79M |
| 5 |
ABV
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
|
+$2.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$10.2M |
| 2 |
Tortoise Energy Infrastructure Corp
TYG
|
+$3.12M |
| 3 |
Coca-Cola
KO
|
+$2.69M |
| 4 |
Procter & Gamble
PG
|
+$2.67M |
| 5 |
Cognizant
CTSH
|
+$2.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.19% |
| 2 | Financials | 10.58% |
| 3 | Technology | 7.75% |
| 4 | Healthcare | 6.49% |
| 5 | Industrials | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Templeton Emerging Markets Income Fund
TEI
$290M
| $901K | 0.21% |
65,750
-6,000
| -8% | -$85.6K |
2013 Q2
2 quarters
|
|
77
VanEck Agribusiness ETF
MOO
$1.14B
| $876K | 0.2% |
16,075
+1,300
| +9% | +$69K |
2013 Q2
2 quarters
|
|
78
AT&T
T
$158B
| $867K | 0.2% |
32,635
| – | – |
2013 Q2
2 quarters
|
|
|
ACC
79
DELISTED
American Campus Communities, Inc.
ACC
| $858K | 0.2% |
26,650
+3,250
| +14% | +$109K |
2013 Q2
2 quarters
|
|
80
Merck
MRK
$364B
| $832K | 0.19% |
17,420
-63
| -0.4% | -$2.88K |
2013 Q2
2 quarters
|
|
|
CMD
81
DELISTED
Cantel Medical Corporation
CMD
| $811K | 0.19% |
23,902
| – | – |
2013 Q2
2 quarters
|
|
|
CELG
82
DELISTED
Celgene Corp
CELG
| $794K | 0.18% |
9,400
| – | – |
2013 Q2
2 quarters
|
|
83
Invesco MSCI Sustainable Future ETF
ERTH
$120M
| $662K | 0.15% |
20,850
| – | – |
2013 Q2
2 quarters
|
|
84
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$290M
| $637K | 0.15% |
33,200
| – | – |
2013 Q2
2 quarters
|
|
85
Goldman Sachs
GS
$256B
| $628K | 0.14% |
3,541
+200
| +6% | +$33K |
2013 Q2
2 quarters
|
|
|
ESRX
86
DELISTED
Express Scripts Holding Company
ESRX
| $617K | 0.14% |
8,786
| – | – |
2013 Q2
2 quarters
|
|
87
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $606K | 0.14% |
+14,500
| New | +$607K |
2013 Q4
0 quarters
|
|
|
ABV
88
DELISTED
COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH
ABV
| $588K | 0.14% |
80,000
+59,175
| +284% | +$2.27M |
2013 Q2
2 quarters
|
|
89
Abbott
ABT
$178B
| $563K | 0.13% |
14,692
-97
| -0.7% | -$3.58K |
2013 Q2
2 quarters
|
|
90
DELISTED
Anadarko Petroleum
APC
| $547K | 0.13% |
6,890
-21,020
| -75% | -$1.88M |
2013 Q2
2 quarters
|
|
91
Verizon
VZ
$185B
| $532K | 0.12% |
10,826
-50
| -0.5% | -$2.46K |
2013 Q2
2 quarters
|
|
92
American Express
AXP
$207B
| $518K | 0.12% |
5,710
-7,156
| -56% | -$588K |
2013 Q2
2 quarters
|
|
93
Vanguard Dividend Appreciation ETF
VIG
$112B
| $515K | 0.12% |
+6,850
| New | +$498K |
2013 Q4
0 quarters
|
|
94
Illinois Tool Works
ITW
$76.7B
| $512K | 0.12% |
6,090
| – | – |
2013 Q2
2 quarters
|
|
|
XBKS
95
DELISTED
XENITH BANKSHARES INC , COMMON STOCK
XBKS
| $512K | 0.12% |
87,000
| – | – |
2013 Q2
2 quarters
|
|
96
Capital Southwest
CSWC
$1.49B
| $511K | 0.12% |
39,901
| – | – |
2013 Q2
2 quarters
|
|
|
ENIA
97
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $510K | 0.12% |
63,036
| – | – |
2013 Q3
1 quarter
|
|
98
APA Corp
APA
$16.6B
| $488K | 0.11% |
5,675
| – | – |
2013 Q2
2 quarters
|
|
|
RDS.A
99
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $486K | 0.11% |
7,302
| – | – |
2013 Q2
2 quarters
|
|
100
iShares MSCI Philippines ETF
EPHE
$132M
| $474K | 0.11% |
15,000
| – | – |
2013 Q2
2 quarters
|
|
Similar funds
GMCM
STI
RRC
CG
SCVF
F
R
SBK
Highmount Capital's Q4 2013 Portfolio in Review
As of Q4 2013, Highmount Capital held 148 positions worth $435M, up 7.4% from $405M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Highmount Capital's Q4 2013 filing shows 18 new, 60 increased, 30 reduced and 4 closed positions. Its largest new stake was Agilent Technologies: 80,532 shares worth $3.29M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $10.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 59% a quarter earlier, followed by Financials and Technology.
- Highmount Capital's largest Q4 2013 buy was Agilent Technologies: 80,532 shares worth $3.29M.
- Highmount Capital added most to Vanguard Short-Term Corporate Bond ETF in Q4 2013, an estimated $3.16M increase.
- Highmount Capital's biggest Q4 2013 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $10.2M.
- Highmount Capital fully exited Cognizant in Q4 2013, selling an estimated $2.03M.
- Highmount Capital's ten largest holdings make up 47% of its $435M portfolio in Q4 2013.
- Highmount Capital opened 18 new positions and closed 4 in Q4 2013.
- Highmount Capital's portfolio value rose 7.4% quarter-over-quarter to $435M.
Based on Highmount Capital's 13F filing for Q4 2013, filed 7 Feb 2014.